Biologics Home Page

Business Overview

Project Management

Process Development

cGMP Manufacture

Track Record

Quality

Analytical Support

Biologics at a Glance

Recruitment

Avecia Biologics Values

Vaccines Business

 

Avecia > Biologics >News

News

20 March 2008
Avecia announces sale of Vaccines business to PharmAthene Inc.

9 October 2007
Barofold and Avecia announce development and manufacturing agreement.

3 October 2007
Listen to Steve Bagshaw, Business director, talk about Avecia's large scale manufacturing capabilities.

2 October 2007
pAVEway™ makes its mark as Avecia makes £1M investment to meet demand.

2 October 2007
Avecia and Renovo announce development and manufacturing agreement.

5 June 2007
Listen to Bo Kara, Director of Science & Technology, talk about the benefits of pAVEway™.

3 May 2007
Avecia launches pAVEway™ – advanced protein expression for the manufacture of biopharmaceuticals.

3 January 2007
Avecia president named as government sector advisory group chair

31 October 2006
Avecia and Illumigen Biosciences announce development & manufacturing agreement

19 September 2006
Biotech Gets a Super Model (BioPharm Services Press Release)

12 June 2006
Avecia to develop anthrax vaccine with improved stability

24 April 2006
Avecia leads wound healing bio-processing team

 


Search
Please type in a keyword or phrase

Avecia Biologics, Billingham, UK

Main news area

Contact us

 

 

 

 

 

Legal Statement and Disclaimer

Home | Site Map | Contact Us